Literature DB >> 11741476

Synthesis and antitumor activity of novel C-7 paclitaxel ethers: discovery of BMS-184476.

T J Altstadt1, C R Fairchild, J Golik, K A Johnston, J F Kadow, F Y Lee, B H Long, W C Rose, D M Vyas, H Wong, M J Wu, M D Wittman.   

Abstract

The preparation of C-7 paclitaxel ethers is described. Various substituted ethers were prepared via activation of the corresponding methylthiomethyl ether followed by alcohol addition. Variation of the C-7 ether group as well the 3' side chain position led to the discovery of a novel taxane, BMS-184476 (4), with preclinical antitumor activity superior to paclitaxel.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11741476     DOI: 10.1021/jm0102607

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

Review 1.  Nanomedicinal strategies to treat multidrug-resistant tumors: current progress.

Authors:  Xiaowei Dong; Russell J Mumper
Journal:  Nanomedicine (Lond)       Date:  2010-06       Impact factor: 5.307

Review 2.  Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology.

Authors:  Xue Xue; Xing-Jie Liang
Journal:  Chin J Cancer       Date:  2012-01-09

3.  Phase I trial of the novel taxane BMS-184476 administered in combination with carboplatin every 21 days.

Authors:  J H Bilenker; J P Stevenson; M L Gallagher; D Vaughn; M B Cohen; P J O'Dwyer
Journal:  Br J Cancer       Date:  2004-07-19       Impact factor: 7.640

Review 4.  Prodrug Strategies for Paclitaxel.

Authors:  Ziyuan Meng; Quanxia Lv; Jun Lu; Houzong Yao; Xiaoqing Lv; Feng Jiang; Aiping Lu; Ge Zhang
Journal:  Int J Mol Sci       Date:  2016-05-23       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.